Literature DB >> 8506375

Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas.

B W Baron1, G Nucifora, N McCabe, R Espinosa, M M Le Beau, T W McKeithan.   

Abstract

Chromosomal translocations involving chromosome 3, band q27, are among the most common rearrangements in B-cell non-Hodgkin lymphoma. From a bacteriophage lambda library prepared from a lymphoma characterized by a t(3;14)(q27;q32), genomic clones were isolated using a probe from the immunoglobulin heavy chain locus (IGH) joining region. In addition to clones containing an apparently normal IGH rearrangement, others were found to contain one of the translocation breakpoint junctions. Normal chromosome 3 sequences and the reciprocal breakpoint junction were subsequently isolated. DNA probes on each side of the chromosome 3 breakpoint hybridized at high stringency to the DNA of various mammalian species, demonstrating evolutionary conservation. One such probe from the presumptive der(3) chromosome detected an 11-kilobase transcript when hybridized to RNA of B- and T-cell lines. A probe made from partial cDNA clones isolated from a T-cell line hybridized with genomic DNA from both sides of the chromosome 3 breakpoint, indicating that the t(3;14) is associated with a break within the gene on chromosome 3. In situ chromosomal hybridization revealed that the same gene is involved in the t(3;22)(q27;q11). Preliminary nucleotide sequencing shows no identity of the cDNA to gene sequences in available data banks. We propose the name BCL6 (B-cell lymphoma 6) for this gene, since it is likely to play a role in the pathogenesis of certain B-cell lymphomas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506375      PMCID: PMC46696          DOI: 10.1073/pnas.90.11.5262

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon.

Authors:  E Brownell; N Mittereder; N R Rice
Journal:  Oncogene       Date:  1989-07       Impact factor: 9.867

2.  The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control.

Authors:  H Ohno; G Takimoto; T W McKeithan
Journal:  Cell       Date:  1990-03-23       Impact factor: 41.582

3.  Long-term growth of malignant thymocytes in vitro.

Authors:  S D Smith; P McFall; R Morgan; M Link; F Hecht; M Cleary; J Sklar
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

4.  Sigma region located between C mu and C delta genes of human immunoglobulin heavy chain: possible involvement of tRNA-like structure in RNA splicing.

Authors:  Y Akahori; H Handa; K Imai; M Abe; K Kameyama; M Hibiya; H Yasui; K Okamura; M Naito; H Matsuoka
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

5.  The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein.

Authors:  E A McGuire; R D Hockett; K M Pollock; M F Bartholdi; S J O'Brien; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

6.  t(3;22)(q27;q11): a novel translocation associated with diffuse non-Hodgkin's lymphoma.

Authors:  K Offit; S Jhanwar; S A Ebrahim; D Filippa; B D Clarkson; R S Chaganti
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

7.  Nonrandom rearrangement of chromosome 14 at band q32.33 in human lymphoid malignancies with mature B-cell phenotype.

Authors:  K Nishida; M Taniwaki; S Misawa; T Abe
Journal:  Cancer Res       Date:  1989-03-01       Impact factor: 12.701

8.  The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias.

Authors:  J D Mellentin; C Murre; T A Donlon; P S McCaw; S D Smith; A J Carroll; M E McDonald; D Baltimore; M L Cleary
Journal:  Science       Date:  1989-10-20       Impact factor: 47.728

9.  Cloning of the chromosome translocation breakpoint junction of the t(14;19) in chronic lymphocytic leukemia.

Authors:  T W McKeithan; J D Rowley; T B Shows; M O Diaz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

10.  A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL.

Authors:  M P Kamps; C Murre; X H Sun; D Baltimore
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

View more
  65 in total

1.  BCL6 canalizes Notch-dependent transcription, excluding Mastermind-like1 from selected target genes during left-right patterning.

Authors:  Daisuke Sakano; Akiko Kato; Nisarg Parikh; Kelly McKnight; Doris Terry; Branko Stefanovic; Yoichi Kato
Journal:  Dev Cell       Date:  2010-03-16       Impact factor: 12.270

2.  Immunophenotypic diagnosis of primary cutaneous lymphomas: a review for the practicing dermatologist.

Authors:  Shannon M Campbell; Sara B Peters; Matthew J Zirwas; Henry K Wong
Journal:  J Clin Aesthet Dermatol       Date:  2010-10

3.  BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.

Authors:  C C Chang; B H Ye; R S Chaganti; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

4.  Glial cell line-derived neurotrophic factor maintains a POZ-itive influence on stem cells.

Authors:  Christopher Payne; Robert E Braun
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

5.  Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: implications for malignant transformation.

Authors:  Xuwei Yang; Koutetsu Lee; Jonathan Said; Xun Gong; Ke Zhang
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

6.  Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.

Authors:  J Iqbal; T C Greiner; K Patel; B J Dave; L Smith; J Ji; G Wright; W G Sanger; D L Pickering; S Jain; D E Horsman; Y Shen; K Fu; D D Weisenburger; C P Hans; E Campo; R D Gascoyne; A Rosenwald; E S Jaffe; J Delabie; L Rimsza; G Ott; H K Müller-Hermelink; J M Connors; J M Vose; T McKeithan; L M Staudt; W C Chan
Journal:  Leukemia       Date:  2007-07-12       Impact factor: 11.528

7.  Structure of the wild-type human BCL6 POZ domain.

Authors:  Mark A Stead; Gareth O Rosbrook; Jonathan M Hadden; Chi H Trinh; Stephen B Carr; Stephanie C Wright
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-11-28

Review 8.  Signaling molecules and pathways regulating the fate of spermatogonial stem cells.

Authors:  Zuping He; Maria Kokkinaki; Martin Dym
Journal:  Microsc Res Tech       Date:  2009-08       Impact factor: 2.769

9.  BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma.

Authors:  Masumichi Saito; Urban Novak; Erich Piovan; Katia Basso; Pavel Sumazin; Christof Schneider; Marta Crespo; Qiong Shen; Govind Bhagat; Andrea Califano; Amy Chadburn; Laura Pasqualucci; Riccardo Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-23       Impact factor: 11.205

Review 10.  Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation.

Authors:  Shane Crotty; Robert J Johnston; Stephen P Schoenberger
Journal:  Nat Immunol       Date:  2010-01-19       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.